Behavioral feedback and rewards for improving functional brain mapping in presurgical pediatric patients
改善术前儿科患者大脑功能图谱的行为反馈和奖励
基本信息
- 批准号:10707227
- 负责人:
- 金额:$ 19.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AphasiaAttention deficit hyperactivity disorderBehavioralBiofeedbackBrainBrain MappingBrain regionChildChildhoodClinicalCognitive deficitsComplexComputer softwareConsumptionDataDevelopmentDreamsEffectivenessElectric StimulationEnrollmentEnvironmentEpilepsyExcisionFailureFeedbackFingersFunctional Magnetic Resonance ImagingFundingHandHeadImageIndividualInformal Social ControlInstitutionInterruptionInterventionIntractable EpilepsyLanguageLanguage DisordersLettersMagnetic Resonance ImagingMapsMarketingMeasuresMedicalMonitorMotionMotorMovementNamesNeurodevelopmental DeficitOperative Surgical ProceduresOutcomeParalysedPatientsPediatricsPhasePhysiciansResearchRewardsRiskRunningSafetyScanningScheduleSeizuresSignal TransductionSmall Business Innovation Research GrantSmall Business Technology Transfer ResearchSpeechSurgeonTechnologyTestingTimeUpdateawakebasechildhood epilepsyclinic readycohortdata qualitydevelopmental psychologyexperienceimprovedinnovationmortalitymotor deficitneurodevelopmentneurosurgerynon-compliancenovelpediatric patientspsychologicsuccesstoolusability
项目摘要
Project Abstract/Summary
The objective of this psychological technology SBIR/STTR Fast-Track proposal is to provide an innovative
gamified biofeedback solution (software-only) to improve the effectiveness of functional Magnetic Resonance
Imaging (fMRI) for pediatric pre-neurosurgical planning. Maximal safe resection of an epileptic focus to
optimize outcome is carefully balanced against impact on critical brain regions that could result in
neurodevelopmental deficits. To avoid deficits such as aphasia or paralysis, surgeons rely on pre-surgical
functional brain mapping to define borders for safe resection. Gold standard, invasive functional brain mapping
via electrocortical stimulation (ECS) is complex, time consuming and carries medical risks (e.g. seizures). It is
extremely challenging for children, to tolerate the often-uncomfortable electrical stimulation. FDA cleared non-
invasive fMRI is a safer alternative for functional mapping. Unfortunately, fMRI has yet to reach its full potential
in pediatrics. Motion as low as 0.2 mm causes distortion of the fMRI signal. Clinical fMRI tasks are also
performed covertly (i.e., no overt speech, no recording of button presses). Functional maps are generated
post-hoc, so scan operators and patients cannot know if sufficient usable data were collected, resulting in 50-
90% clinical pediatric fMRI failure rates due to motion and poor task compliance. NOUS Imaging Inc. has
developed FDA 510(k)-cleared Framewise Integrated Real-Time MRI Monitoring (FIRMM) software for tracking
motion and its effects. Use of FIRMM can greatly improve the chances of obtaining usable fMRI maps,
reducing fMRI data loss rates due to motion by >50% in children. FIRMM currently displays brain motion to the
scan operator and patient in real-time, enabling scan operator intervention and patient self-regulation. In this
Fast-Track application, we will extend development from FIRMM to FIRMM Qx with gamified biofeedback and
task compliance tracking, to provide a new, neuro-developmentally appropriate, biofeedback-based quality
improvement solution for pediatric clinical fMRI. In Phase I we will develop and verify FIRMM Qx as a tool to
greatly reduce fMRI mapping failures due to non-compliance, motion or both. In Phase II, we will demonstrate
that FIRMM Qx is superior to fMRI without real-time QC and biofeedback, providing more accurate maps and
lower non-invasive brain mapping fail-rates for pediatric epilepsy surgery planning. NordicNeuroLab (NNL) is
the leading supplier of fMRI hardware and software, used for fMRI at > 2000 institutions worldwide. However,
NNL fMRI fails whenever insufficient quality fMRI data are collected. A new, synergistic partnership between
NOUS and NNL will add FIRMM Qx real-time motion and task compliance improvement to NNL fMRI. NOUS
will be providing developmental psychology know-how, while NNL provides best-in-class fMRI hardware, post-
processing and a large distribution network. Adding FIRMM Qx, to the NOUS portfolio and NNL user base will
make epilepsy surgery for children better and safer.
项目摘要/摘要
这种心理技术SBIR/STTR Fast-Track建议的目的是提供创新的
游戏化生物反馈解决方案(仅软件)以提高功能磁共振的有效性
小儿神经外科外科计划的成像(fMRI)。将癫痫焦点的最大安全切除到
优化结果与对关键大脑区域的影响仔细平衡,这可能导致
神经发育缺陷。为了避免失语或瘫痪等缺陷,外科医生依靠外科医师
功能性大脑映射以定义边界以进行安全切除。黄金标准,侵入性功能性脑图
通过皮质刺激(EC)很复杂,耗时并带有医疗风险(例如癫痫发作)。这是
对于儿童来说,极具挑战性,可以容忍通常不舒服的电刺激。 FDA清除了非 -
入侵fMRI是功能映射的更安全的替代方案。不幸的是,fMRI尚未发挥全部潜力
在儿科。低至0.2 mm的运动会导致fMRI信号的失真。临床fMRI任务也是
秘密执行(即没有公开的语音,没有按钮按下的记录)。生成功能图
事后,因此扫描操作员和患者不知道是否收集了足够的可用数据,导致50-
由于运动和任务依从性差而导致的90%临床小儿fMRI失败率。 Nous Imaging Inc.
开发了FDA 510(k)切实的框架框架集成的实时MRI监控(FIRMEM)软件用于跟踪
运动及其影响。使用Firmm可以大大提高获得可用的fMRI地图的机会,
儿童的运动损失率降低了50%。 FINDM目前将脑运动显示为
实时扫描操作员和患者,使扫描操作员干预和患者自我调节。在这个
快速轨道应用程序,我们将使用Gamifiend Biofefback和
任务合规性跟踪,提供一种新的,神经开发的基于生物反馈的质量
小儿临床fMRI的改进解决方案。在第一阶段,我们将开发并验证firmm qx作为一种工具
由于不合规,运动或两者兼而有之,大大减少了fMRI映射失败。在第二阶段,我们将证明
没有实时QC和Biofefback,Firmm QX优于fMRI,提供了更准确的地图和
小儿癫痫手术计划的降低非侵入性大脑图率。 Nordicneurolab(NNL)是
fMRI硬件和软件的领先供应商,用于> 2000年在全球> 2000机构的fMRI。然而,
每当收集质量不足FMRI数据时,NNL fMRI失败。一种新的协同伙伴关系
NOUS和NNL将为NNL fMRI添加Firmm QX实时运动和任务合规性改进。 nous
将提供发展心理学专业知识,而NNL提供一流的fMRI硬件,后
处理和大型分销网络。将Firmm QX添加到NOUS组合和NNL用户群中
为儿童做癫痫手术更好,更安全。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ken Bruener其他文献
Ken Bruener的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ken Bruener', 18)}}的其他基金
Framewise Integrated Real-Time MRI Monitoring (FIRMM) software commercialization readiness for clinical care
逐帧集成实时 MRI 监测 (FIRMM) 软件为临床护理做好商业化准备
- 批准号:
10697965 - 财政年份:2023
- 资助金额:
$ 19.88万 - 项目类别:
Behavioral feedback and rewards for improving functional brain mapping in presurgical pediatric patients
改善术前儿科患者大脑功能图谱的行为反馈和奖励
- 批准号:
10546990 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别:
Commercialization readiness of visual biofeedback to reduce head motion during MRI scans
视觉生物反馈已做好商业化准备,以减少 MRI 扫描期间的头部运动
- 批准号:
10382713 - 财政年份:2021
- 资助金额:
$ 19.88万 - 项目类别:
Commercialization readiness of visual biofeedback to reduce head motion during MRI scans
视觉生物反馈已做好商业化准备,以减少 MRI 扫描期间的头部运动
- 批准号:
10532740 - 财政年份:2021
- 资助金额:
$ 19.88万 - 项目类别:
Visual biofeedback to reduce head motion during MRI scans
视觉生物反馈可减少 MRI 扫描期间的头部运动
- 批准号:
10199977 - 财政年份:2019
- 资助金额:
$ 19.88万 - 项目类别:
Visual biofeedback to reduce head motion during MRI scans
视觉生物反馈可减少 MRI 扫描期间的头部运动
- 批准号:
10437644 - 财政年份:2019
- 资助金额:
$ 19.88万 - 项目类别:
Visual biofeedback to reduce head motion during MRI scans
视觉生物反馈可减少 MRI 扫描期间的头部运动
- 批准号:
10442332 - 财政年份:2019
- 资助金额:
$ 19.88万 - 项目类别:
相似国自然基金
执行技能训练联合动机行为治疗对注意缺陷多动障碍青少年疗效及脑机制
- 批准号:82371557
- 批准年份:2023
- 资助金额:65 万元
- 项目类别:面上项目
注意缺陷多动障碍儿童青春期前执行功能发育轨迹的纵向随访研究
- 批准号:82371548
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Per1调控注意缺陷多动障碍的机制研究
- 批准号:82371544
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
生命早期肠道菌群构建与儿童注意缺陷多动障碍的关系及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Leptin/STAT3信号通路受损介导宫内营养不良致注意缺陷多动障碍的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Behavioral feedback and rewards for improving functional brain mapping in presurgical pediatric patients
改善术前儿科患者大脑功能图谱的行为反馈和奖励
- 批准号:
10546990 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别:
Neurodevelopment in children from families with genetic frontotemporal dementia and Alzheimer’s disease
遗传性额颞叶痴呆和阿尔茨海默病家族儿童的神经发育
- 批准号:
10364525 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别:
Neurodevelopment in children from families with genetic frontotemporal dementia and Alzheimer's disease
遗传性额颞叶痴呆和阿尔茨海默病家庭儿童的神经发育
- 批准号:
10632707 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别:
Neurodevelopment in children from families with genetic frontotemporal dementia and Alzheimer’s disease
遗传性额颞叶痴呆和阿尔茨海默病家族儿童的神经发育
- 批准号:
10571880 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别:
Neurodevelopment in children from families with genetic frontotemporal dementia and Alzheimer’s disease
遗传性额颞叶痴呆和阿尔茨海默病家族儿童的神经发育
- 批准号:
10810931 - 财政年份:2022
- 资助金额:
$ 19.88万 - 项目类别: